FDA Inspection
Amphastar Nanjing Pharmaceuticals IncAmphastar Nanjing Pharmaceuticals Inc – FDA Inspection, Sep 19, 2025
Record Details
This FDA Inspection record concerns Amphastar Nanjing Pharmaceuticals Inc, with an inspection on September 19, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- September 19, 2025
- Product Type
- Human Drugs
View Company Profile
ID · 8c11e7e8-9c3d-43fb-940f-6748a59595b1
Inspection Facts
- Inspection number
- 1291882
- FDA center
- Human Drugs
Other FDA inspections of Amphastar Nanjing Pharmaceuticals Inc
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 7, 2025 | Not classified | Office of Inspections and Investigations | |
| October 11, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 26, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 28, 2017 | Not classified | Office of Inspections and Investigations | |
| April 29, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Amphastar Nanjing Pharmaceuticals Inc
- FDA Inspection 1269036 - 2025-03-07
- FDA Inspection 1107981 - 2019-10-11
- FDA Inspection 1036696 - 2017-10-26
- FDA Inspection 1017547 - 2017-04-28
- FDA Inspection 969870 - 2016-04-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.